000 01271 a2200385 4500
005 20250514220739.0
264 0 _c20050428
008 200504s 0 0 eng d
022 _a0021-1265
024 7 _a10.1007/BF02914519
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Brien, M F
245 0 0 _aShould patients with a pre-operative prostate-specific antigen greater than 15 ng/ml be offered radical prostatectomy?
_h[electronic resource]
260 _bIrish journal of medical science
_c
300 _a23-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xblood
650 0 4 _aPatient Selection
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatectomy
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aReference Values
650 0 4 _aTreatment Outcome
700 1 _aConnolly, S S
700 1 _aKelly, D G
700 1 _aO'Brien, A
700 1 _aQuinlan, D M
700 1 _aMulvin, D W
773 0 _tIrish journal of medical science
_gvol. 173
_gno. 1
_gp. 23-6
856 4 0 _uhttps://doi.org/10.1007/BF02914519
_zAvailable from publisher's website
999 _c15406716
_d15406716